Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
3,732
Views
27
CrossRef citations to date
0
Altmetric
Back Matter

Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment

Min Yanga Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, ChangzhouChina;b Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USAView further author information
,
Wenwen Dub Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USA;c Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, ChinaView further author information
,
Lixian Yib Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USA;d Suzhou Vocational Health College, Suzhou, ChinaView further author information
,
Shaoxian Wua Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, ChangzhouChina;b Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USAView further author information
,
Chunyan Heb Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USAView further author information
,
Wensi Zhaia Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, ChangzhouChina;b Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USAView further author information
,
Cuihua Yuea Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, ChangzhouChina;b Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USAView further author information
,
Runzi Suna Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, ChangzhouChina;b Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USAView further author information
,
Ashley V. Menke Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PAUSAView further author information
,
Greg M. Delgoffeb Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USA;e Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PAUSAView further author information
,
Jingting Jianga Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, ChangzhouChinaView further author information
&
Binfeng Lub Department of Immunology, School of Medicine, University of Pittsburgh, PittsburghPA, USACorrespondence[email protected]
View further author information
 show all
Article: 1708064 | Received 31 Jan 2019, Accepted 27 Oct 2019, Published online: 30 Jan 2020

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, Erika Vacchelli & Guido Kroemer. (2020) Trial watch: STING agonists in cancer therapy. OncoImmunology 9:1.
Read now

Articles from other publishers (26)

Ru He, Shangke Huang, Jiaan Lu, Lanqian Su, Xinrui Gao & Hao Chi. (2024) Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions. Frontiers in Immunology 15.
Crossref
Richard Miallot, Virginie Millet, Anais Roger, Romain Fenouil, Catherine Tardivel, Jean-Charles Martin, Fabrice Tranchida, Laetitia Shintu, Paul Berchard, Juliane Sousa Lanza, Bernard Malissen, Sandrine Henri, Sophie Ugolini, Aurélie Dutour, Pascal Finetti, François Bertucci, Jean-Yves Blay, Franck Galland & Philippe Naquet. (2023) The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma. Life Science Alliance 6:12, pages e202302200.
Crossref
Shaoxian Wu, Hao Huang, Runzi Sun, David Shihong Gao, Fan Ye, Jianing Huang, Ella Li, Andrew Ni, Kevin GuoKai Lu, Kong Chen, Jingting Jiang, Penelope A. Morel, Ziyang Zhong & Binfeng Lu. (2023) Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment. Cancer Research Communications 3:8, pages 1460-1472.
Crossref
雪 许. (2023) Research Progress of Tim-3/Gal-9 Signaling Pathway in the Treatment of Acute Graft-Versus-Host Disease in Mesenchymal Stem Cells. Advances in Clinical Medicine 13:03, pages 4919-4925.
Crossref
Claudia Giannotta, Barbara Castella, Ezio Tripoli, Daniele Grimaldi, Ilaria Avonto, Mattia D’Agostino, Alessandra Larocca, Joanna Kopecka, Mariella Grasso, Chiara Riganti & Massimo Massaia. (2022) Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status. Frontiers in Immunology 13.
Crossref
Jessica C. Leete, Michael G. Zager, Cynthia J. Musante, Blerta Shtylla & Wenlian Qiao. (2022) Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework. Frontiers in Pharmacology 13.
Crossref
Shan Qiao, Yunfang Xie, Haiyun Li, Ranran Zhang, Yujiao Wu, Xuewu Liu & ShanChao Zhang. (2022) Cytokines/chemokines and soluble immune checkpoint molecules in anti-GABAB receptor encephalitis. Multiple Sclerosis and Related Disorders 68, pages 104234.
Crossref
Yanyan Xu, Jingyuan Xiong, Xiyang Sun & Huile Gao. (2022) Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy. Acta Pharmaceutica Sinica B 12:12, pages 4327-4347.
Crossref
Dong Shao, Yaping Chen, Hao Huang, Yingting Liu, Junjun Chen, Dawei Zhu, Xiao Zheng, Lujun Chen & Jingting Jiang. (2022) LAG3 blockade coordinates with microwave ablation to promote CD8+ T cell-mediated anti-tumor immunity. Journal of Translational Medicine 20:1.
Crossref
Yixue Xia, Binghong Gao & Xue Zhang. (2022) Targeting mitochondrial quality control of T cells: Regulating the immune response in HCC. Frontiers in Oncology 12.
Crossref
Julian L. Goggi, Shivashankar Khanapur, Siddesh V. Hartimath, Boominathan Ramasamy, Peter Cheng, Hui-Xian Chin, Jun-Rong Tang, You-Yi Hwang & Edward G. Robins. (2022) Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer. Biomedicines 10:10, pages 2343.
Crossref
Lujun Chen, Hao Huang, Xiao Zheng, Yuan Li, Junjun Chen, Bo Tan, Yingting Liu, Runzi Sun, Bin Xu, Min Yang, Bin Li, Changping Wu, Binfeng Lu & Jingting Jiang. (2022) IL1R2 increases regulatory T cell population in the tumor microenvironment by enhancing MHC-II expression on cancer-associated fibroblasts. Journal for ImmunoTherapy of Cancer 10:9, pages e004585.
Crossref
Md Nabiul Hasan, Okan Capuk, Shivani M. Patel & Dandan Sun. (2022) The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity. Cancers 14:14, pages 3331.
Crossref
Lishu ZhaoHao WangKandi XuXinyue LiuYayi He. (2022) Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications. Chinese Medical Journal 135:10, pages 1203-1212.
Crossref
Adrià Archilla-Ortega, Carla Domuro, Juan Martin-Liberal & Purificación Muñoz. (2022) Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Xue Cui, Min Peng & Honglei Chen. (2022) The Emerging Role of Lymphocyte Activation Gene 3 in the Cancer Immunotherapy. Oncologie 24:4, pages 665-678.
Crossref
Elien De Bousser, Nico Callewaert & Nele Festjens. (2021) T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy. Cancers 13:23, pages 6067.
Crossref
Yingqi Qiu, Tong Chen, Rong Hu, Ruiyi Zhu, Chujun Li, Yingchen Ruan, Xiaoling Xie & Yuhua Li. (2021) Next frontier in tumor immunotherapy: macrophage-mediated immune evasion. Biomarker Research 9:1.
Crossref
Chengguo Li, Qian Shen, Peng Zhang, Tao Wang, Weizhen Liu, Ruidong Li, Xianxiong Ma, Xiangyu Zeng, Yuping Yin & Kaixiong Tao. (2021) Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Shaoxian Wu, Runzi Sun, Bo Tan, Bendong Chen, Wenyan Zhou, David Shihong Gao, Joshua Zhong, Hao Huang, Jingting Jiang & Binfeng Lu. (2021) The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy. Frontiers in Cell and Developmental Biology 9.
Crossref
Lorenzo Galluzzi & Abhishek D. Garg. (2021) Immunology of Cell Death in Cancer Immunotherapy. Cells 10:5, pages 1208.
Crossref
Chuang Zhang, Danni Li, Ruoxi Yu, Ce Li, Yujia Song, Xi Chen, Yibo Fan, Yunpeng Liu & Xiujuan Qu. (2021) Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Frontiers in Immunology 12.
Crossref
Diana L. Bonilla, Gil Reinin & Edmond Chua. (2021) Full Spectrum Flow Cytometry as a Powerful Technology for Cancer Immunotherapy Research. Frontiers in Molecular Biosciences 7.
Crossref
Runzi Sun, Yixian Wu, Huijun Zhou, Yanshi Wu, Zhongzhou Yang, Yanzheng Gu, Jingting Jiang, Binfeng Lu & Yibei Zhu. (2021) Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8+ T Cells. Frontiers in Cell and Developmental Biology 9.
Crossref
Sungjae Kim, Ahreum Kim, Jong-Yeon Shin & Jeong-Sun Seo. (2020) The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types. Scientific Reports 10:1.
Crossref
Qiu-xia Qu, Xin-yun Zhu, Wen-wen Du, Hong-bin Wang, Yu Shen, Yi-bei Zhu & Cheng Chen. (2020) 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation. Frontiers in Immunology 11.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.